Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of two different models to predict BRCA1 and BRCA2 mutations in a cohort of Danish hereditary breast and/or ovarian cancer families.

Clinical genetics - 1 Feb 2006

Gerdes A-M, Cruger D G, Thomassen M, Kruse T A

Abstract excerpt

To meet the increasing demand for BRCA1 and BRCA2 mutation analysis, a robust system for selecting families who have a higher chance of a mutation has become important. Several models have been developed to help predict which samples are more likely to be mutation positive than others. We have un...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to BRCA2 Protein
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cohort Studies

Share to DNA Mutational Analysis

Share to Models, Genetic

Share to Netherlands

Share to Ovarian Neoplasms

Source

Identifiers

PMID: 16433698
DOI: 10.1111/j.1399-0004.2006.00568.x

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-16433698-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of two different models to predict BRCA1 and BRCA2 mutations in a cohort of Danish hereditary breast and/or ovarian cancer families.PMID 16433698Read ↗

Evaluation of models to predict BRCA germline mutations.Semantic proximity Read ↗

Development of a scoring system to screen for BRCA1/2 mutations.Semantic proximity Read ↗

Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancer.Semantic proximity Read ↗

Efficiency of BRCAPRO and Myriad II mutation probability thresholds versus cancer history criteria alone for BRCA1/2 mutation detection.Semantic proximity Read ↗

Validation of three BRCA1/2 mutation-carrier probability models Myriad, BRCAPRO and BOADICEA in a population-based series of 183 German families.Semantic proximity Read ↗

Validation of the Manchester scoring system for predicting BRCA1/2 mutations in 9,390 families suspected of having hereditary breast and ovarian cancer.Semantic proximity Read ↗

Accuracy of BRCA1/2 mutation prediction models in Korean breast cancer patients.Semantic proximity Read ↗

Selecting a BRCA risk assessment model for use in a familial cancer clinic.Semantic proximity Read ↗

Performance of BRCA1/2 mutation prediction models in male breast cancer patients.Semantic proximity Read ↗

Validity of models for predicting BRCA1 and BRCA2 mutations.Semantic proximity Read ↗

Screening of 1331 Danish breast and/or ovarian cancer families identified 40 novel BRCA1 and BRCA2 mutations.Semantic proximity Read ↗

Evaluation of BRCA1 and BRCA2 mutations and risk-prediction models in a typical Asian country (Malaysia) with a relatively low incidence of breast cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.